Abstract
Abstract
Background
Polymers are essential components of many drug delivery systems and biomedical products. Despite the utility of many currently available polymers, there exists a demand for materials with improved characteristics and functionality. Due to the extensive safety testing required for new excipient approval, the introduction and use of new polymers is considerably limited. The blending of currently approved polymers provides a valuable solution by which the limitations of individual polymers can be addressed.
Main body
Polymer blends combine two or more polymers resulting in improved, augmented, or customized properties and functionality which can result in significant advantages in drug delivery applications. This review discusses the rationale for the use of polymer blends and blend polymer-polymer interactions. It provides examples of their use in commercially marketed products and drug delivery systems. Examples of polymer blends in amorphous solid dispersions and biodegradable systems are also discussed. A classification scheme for polymer blends based on the level of material processing and interaction is presented.
Conclusion
The use of polymer blends represents a valuable and under-utilized resource in addressing a diverse range of drug delivery challenges. It is anticipated that new drug molecule development challenges such as bioavailability enhancement and the demand for enabling excipients will lead to increased applications of polymer blends in pharmaceutical products.
Graphical abstract
Publisher
Springer Science and Business Media LLC
Reference129 articles.
1. Imre B, Pukánszky B (2013) Compatibilization in bio-based and biodegradable polymer blends. Eur Polym J 49:1215–1233. https://doi.org/10.1016/j.eurpolymj.2013.01.019
2. Gusler G, Berner B, Chau M, Padua A (2004) Optimal polymer mixtures for gastric retentive tablets, US Patent 6,723,340B2, 2004
3. Staniforth JN, Baichwal AR (2005) TIMERx: novel polysaccharide composites for controlled/programmed release of drugs in the gastrointestinal tract. Expert Opin Drug Deliv 2:587–595. https://doi.org/10.1517/17425247.2.3.587
4. McGinley EJ, Tuason DC (1993) Fat-like bulking agent for aqueous foods comprising microcrystalline cellulose and a galactomannan gum, US Patent 5,192,569A, 1993
5. Koo OM, Fiske JD, Yang H, Nikfar F, Thakur A, Scheer B, Adams ML (2011) Investigation into stability of poly(vinyl alcohol)-based Opadry® II films. AAPS PharmSciTech 12:746–754. https://doi.org/10.1208/s12249-011-9630-1
Cited by
51 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献